These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

371 related items for PubMed ID: 8781336

  • 1. Antifibrogenic effect of a deletion variant of hepatocyte growth factor on liver fibrosis in rats.
    Yasuda H, Imai E, Shiota A, Fujise N, Morinaga T, Higashio K.
    Hepatology; 1996 Sep; 24(3):636-42. PubMed ID: 8781336
    [Abstract] [Full Text] [Related]

  • 2.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 3. Interferon gamma decreases hepatic stellate cell activation and extracellular matrix deposition in rat liver fibrosis.
    Baroni GS, D'Ambrosio L, Curto P, Casini A, Mancini R, Jezequel AM, Benedetti A.
    Hepatology; 1996 May; 23(5):1189-99. PubMed ID: 8621153
    [Abstract] [Full Text] [Related]

  • 4. Antifibrotic effects of tetrandrine on hepatic stellate cells and rats with liver fibrosis.
    Hsu YC, Chiu YT, Cheng CC, Wu CF, Lin YL, Huang YT.
    J Gastroenterol Hepatol; 2007 Jan; 22(1):99-111. PubMed ID: 17201889
    [Abstract] [Full Text] [Related]

  • 5. Anti-fibrotic effects of the anthocyanins isolated from the purple-fleshed sweet potato on hepatic fibrosis induced by dimethylnitrosamine administration in rats.
    Choi JH, Hwang YP, Choi CY, Chung YC, Jeong HG.
    Food Chem Toxicol; 2010 Nov; 48(11):3137-43. PubMed ID: 20728498
    [Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7. Remote delivery and expression of soluble type II TGF-beta receptor in muscle prevents hepatic fibrosis in rats.
    Nakamuta M, Morizono S, Tsuruta S, Kohjima M, Kotoh K, Enjoji M.
    Int J Mol Med; 2005 Jul; 16(1):59-64. PubMed ID: 15942678
    [Abstract] [Full Text] [Related]

  • 8. Preventive and therapeutic effects in rats of hepatocyte growth factor infusion on liver fibrosis/cirrhosis.
    Matsuda Y, Matsumoto K, Yamada A, Ichida T, Asakura H, Komoriya Y, Nishiyama E, Nakamura T.
    Hepatology; 1997 Jul; 26(1):81-9. PubMed ID: 9214455
    [Abstract] [Full Text] [Related]

  • 9. Effects of RNA interference targeting transforming growth factor-beta 1 on immune hepatic fibrosis induced by Concanavalin A in mice.
    Xu W, Wang LW, Shi JZ, Gong ZJ.
    Hepatobiliary Pancreat Dis Int; 2009 Jun; 8(3):300-8. PubMed ID: 19502172
    [Abstract] [Full Text] [Related]

  • 10. Effects of perindopril and valsartan on expression of transforming growth factor-beta-Smads in experimental hepatic fibrosis in rats.
    Xu W, Song S, Huang Y, Gong Z.
    J Gastroenterol Hepatol; 2006 Aug; 21(8):1250-6. PubMed ID: 16872305
    [Abstract] [Full Text] [Related]

  • 11. Targeted disruption of Smad3 confers resistance to the development of dimethylnitrosamine-induced hepatic fibrosis in mice.
    Latella G, Vetuschi A, Sferra R, Catitti V, D'Angelo A, Zanninelli G, Flanders KC, Gaudio E.
    Liver Int; 2009 Aug; 29(7):997-1009. PubMed ID: 19422482
    [Abstract] [Full Text] [Related]

  • 12. Hepatocyte growth factor prevents chronic allograft dysfunction in liver-transplanted rats.
    Tashiro H, Fudaba Y, Itoh H, Mizunuma K, Ohdan H, Itamoto T, Asahara T.
    Transplantation; 2003 Sep 15; 76(5):761-5. PubMed ID: 14501849
    [Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14. Interferon gamma inhibits lipocyte activation and extracellular matrix mRNA expression during experimental liver injury: implications for treatment of hepatic fibrosis.
    Rockey DC, Chung JJ.
    J Investig Med; 1994 Dec 15; 42(4):660-70. PubMed ID: 8521029
    [Abstract] [Full Text] [Related]

  • 15. Adenoviral delivery of an antisense RNA complementary to the 3' coding sequence of transforming growth factor-beta1 inhibits fibrogenic activities of hepatic stellate cells.
    Arias M, Lahme B, Van de Leur E, Gressner AM, Weiskirchen R.
    Cell Growth Differ; 2002 Jun 15; 13(6):265-73. PubMed ID: 12114216
    [Abstract] [Full Text] [Related]

  • 16. Sequential assessment of the intrahepatic expression of epidermal growth factor and transforming growth factor-beta1 in hepatofibrogenesis of a rat cirrhosis model.
    Kuriyama S, Yokoyama F, Inoue H, Takano J, Ogawa M, Kita Y, Yoshiji H, Deguchi A, Kimura Y, Himoto T, Yoneyama H, Kurokohchi K, Masaki T, Uchida N, Watanabe S.
    Int J Mol Med; 2007 Feb 15; 19(2):317-24. PubMed ID: 17203207
    [Abstract] [Full Text] [Related]

  • 17. Taurine inhibits oxidative damage and prevents fibrosis in carbon tetrachloride-induced hepatic fibrosis.
    Miyazaki T, Karube M, Matsuzaki Y, Ikegami T, Doy M, Tanaka N, Bouscarel B.
    J Hepatol; 2005 Jul 15; 43(1):117-25. PubMed ID: 15893842
    [Abstract] [Full Text] [Related]

  • 18. The flavonoid quercetin inhibits dimethylnitrosamine-induced liver damage in rats.
    Lee ES, Lee HE, Shin JY, Yoon S, Moon JO.
    J Pharm Pharmacol; 2003 Aug 15; 55(8):1169-74. PubMed ID: 12956909
    [Abstract] [Full Text] [Related]

  • 19. Suppressive effects of estradiol on dimethylnitrosamine-induced fibrosis of the liver in rats.
    Yasuda M, Shimizu I, Shiba M, Ito S.
    Hepatology; 1999 Mar 15; 29(3):719-27. PubMed ID: 10051473
    [Abstract] [Full Text] [Related]

  • 20. Transforming growth factor-beta 1 and type I procollagen transcripts during regeneration and early fibrosis of rat liver.
    Nakatsukasa H, Evarts RP, Hsia CC, Thorgeirsson SS.
    Lab Invest; 1990 Aug 15; 63(2):171-80. PubMed ID: 2381163
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 19.